Akasi Pharma

Copenhagen, Denmark

Akasi Pharma focuses on developing peptide-based therapeutics aimed at treating peripheral pain conditions.

$526K raised

Feb 2025

Pre-Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Akasi Pharma raised?

Akasi Pharma has raised $526K in total funding. The most recent round was Pre-Seed. The last funding was announced in February 2025.

Who are Akasi Pharma's investors?

Akasi Pharma's investors include BioInnovation Institute Venture Lab.

Where is Akasi Pharma headquartered?

Akasi Pharma is headquartered in Copenhagen, Denmark.

What does Akasi Pharma do?

Akasi Pharma focuses on developing peptide-based therapeutics aimed at treating peripheral pain conditions.

What stage is Akasi Pharma at?

Akasi Pharma is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 25, 2025.

MLA

"Akasi Pharma — Funding & Investors." VCBacked, February 25, 2025, https://www.vcbacked.co/company/akasi-pharma. Accessed July 2, 2026.

APA

VCBacked. (2025). Akasi Pharma — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/akasi-pharma

Wikipedia (cite web)

{{cite web |title=Akasi Pharma — Funding & Investors |url=https://www.vcbacked.co/company/akasi-pharma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 25, 2025.